nals.
Dr. Hu stated, "Dr. Li Tao has considerable experience and has also shown
his ability to consistently publish innovative research. We will look to his
strong leadership skills when directing the research and development work of
our iPS laboratory. This is a young field; his experience in senior roles in
Japan and the U.S. is a great asset to our goal of being at the cutting-edge
of research." With nine full-time researchers, the iPS lab's main focus is the
safe manufacture of iPS cells for insulin production.
Dr. Susan Jiang began her career path as a physician in the field of
otorhinolaryngology, specializing in head and neck (ENT-HN) surgery. After
receiving her Ph.D. in China, she completed post-doctoral work in the
Department of Physiology Biophysics at the University of Arkansas in 2002. In
2005, Dr. Jiang moved to the Pediatrics Department of Stanford University
where she investigated the therapeutic potential of stem cells in neo-natal
respiratory diseases and developed wound healing models based on stem cell
technologies. After nearly three years at Stanford, she became Scientific
Director at Escape Therapeutics in the U.S., managing their science team as
they developed products based on genetically engineered human stem cells and
beta cells for diabetic-related disorders.
Dr. Hu expressed his excitement over the recruitment of Susan Jiang: "Dr.
Jiang's international clinical and laboratory experience gives her the right
background to help us validate our current technologies internationally. She
will also take on task of refining our stem cell cultivation processes and
advancing the clinical development of our treatment protocols,"
Dr. Jiang added, "I decided to come back to China because of the nurturing
research environment, where the government has consistently provided a
supportive and practical regulatory framework with generous access t
'/>"/>
SOURCE Shenzhen Beike Biotechnology Co. Ltd. Copyright©2009 PR Newswire. All rights reserved | |
Page: 1 2 3 Related biology technology :1.
Stem Cell Leader Beike Signs 8 New Cooperation Agreements, Establishes Safety Monitoring Boards2.
Beike Biotech Opens Comprehensive Stem Cell Storage and Processing Facility in China3.
Former Manchester City Lord Mayor Has Hope Restored at New Beike Stem Cell Facility4.
Stem Cell Leader Beike Biotech and Chinas Tsinghua University Receive US$4 Million for Stem Cell Reprogramming Laboratory5.
Transcept Pharmaceuticals to Present at the BioCentury Thomson Reuters Newsmakers in the Biotech Industry Conference on September 16, 20096.
TechConnect World 2010 Solving Global Technology Challenges with Clean Technology, Nanotechnology and Biotechnology7.
Biotech Cools Off in August But Capital Markets Remain Positive8.
China Kangtai Cactus Biotech to Launch Patented Cactus-based Low Tar, Low or Zero Nicotine Cigarettes9.
Champions Biotechnology to Deploy its Technology to Guide Development of Oncology Therapeutic for Global Biotech Leader10.
Oncolytics Biotech(R) Inc. Announces Issuance of 32nd U.S. Patent11.
SABiosciences Ranked 17th on the Best Places to Work Industry Award for Biotech and Pharmaceutical Companies